IRIDEX Corp (IRIX, Financial) experienced a significant stock movement with a 6.15% increase in its share price, reaching $1.90. The trading volume was 36,983 shares, with a turnover rate of 0.22% and a price fluctuation of 3.91%. Recent financial reports show the company earned $11.58 million in revenue, with a net loss of $1.93 million, resulting in an EPS of -$0.12 and a negative P/E ratio of -2.73. Currently, no institutional ratings are available for IRIX.
In the medical device sector, where IRIDEX operates, there was an overall decline of 0.71%. Notable performers in the sector included Spectral Ai Inc and Novocure Limited, with Spectral Ai, Inc. showing high activity and turnover rates. IRIDEX specializes in developing and selling laser medical systems and ophthalmic devices, leveraging proprietary micro-pulse technology, with major revenue from the U.S., Europe, and other regions.